INDUSTRY INSIGHTS YOUR PEERS ARE READING
La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 ambrx pricing merger acquisition nasdaq ambx exit biotech lifescience biopharma biopharmaceuticals protein antibody MORE
The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million. MORE
Thousand Oaks-based Ceres , the developer of seeds for producing renewable bioenergy feedstocks, has cut its estimated IPO pricing range, ahead of its anticipated IPO this week. In an updated S-1, Ceres now estimates that it will price at between $16.00 MORE
Culver City-based NantHealth , one of the startups out of billionaire Patrick Soon-Shiong's NantWorks portfolio, has set its IPO pricing range at between $12.50 The next step in the IPO process is the company's roadshow to investors and actual pricing of an IPO. nanthealth nantworks merger acquisition pricing personalized medicine MORE
TubeMogul , which develops software to help advertisers with their online video buying, priced its IPO last night, offering up 6,250,000 shares of its common stock at $7.00 tubemogul software digital video advertising merger acquisition exit per share. The company will starts trading this morning on the NASDAQ Global Select Market as TUBE. MORE
Los Angeles-based Beyond Meat , which develops plant-based meat products, which look and taste like real meat, has set its IPO pricing range, as its preps to go public. According to Beyond Meat, it expects an initial offering price of between $19.00 beyond meat pricing merger acquisition bynd vegetarian veggie burger food consumer exit MORE
has officially priced its IPO, saying on Wednesday afternoon that it will sell 200M shares of its common stock at $17.00 Snap's IPO priced above its initial estimated pricing range, which had been between $14.00 snap snapchat merger acquisition exit evan spiegel bobby murphy millionaire billionaireVenice, California-based Snap, Inc. per share. The IPO will raise $3.4 billion for Snap, the company behind Snapchat , valuing the company at approximately $24 billion. MORE
Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 per share IPO range, after seeing a delay of a week in the expected pricing by the firm. MORE
SendGrid , the developer of email delivery tools and back-end email services with operations in Irvine, has set its estimated IPO pricing range this morning, saying it is looking to sell 7,700,000 shares of its common stock at between $13.50 sendgrid merger acquisition send email delivery service server isaac saldana irvine MORE
Woodland Hills-based BlackLine Software , the developer of accounting and financial close software, has priced its IPO, saying late Thursday evening that it will sell 8,600,000 shares of its common stock at $17.00 BlackLine priced at the high range of an already increased estimated IPO range, which was set to $16.00 saas software accounting acquisition merger blackline MORE
[ Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual few days of the J.P. Morgan Healthcare Conference and everything that mushrooms around it seem just as long as the holiday break—a distant memory!—that —that came just before. In 2020 (yes, that’s really a year), San Francisco might have a new mayor. MORE
San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 tandem diabetes care diabetic medical device exit merger acquisition tndm per share. The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM. MORE
San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 ambit biosciences lifescience merger acquisition MORE
In a sign that reception to the company's IPO is going well, Ventura-based The Trade Desk said in a regulatory filing on Monday that it now expects its initial public offering price to be between $16.00 accelerator marketplace market exchange advertising acquisition merger pricing desk trade MORE
Ventura-based The Trade Desk has set the initial estimated pricing range for its IPO, saying in a filing on Tuesday that it now expects its IPO to be between $14.00 trade desk tradedesk merger acquisition advertisingand $16.00 per share. The company is selling 4,666,667 shares of its common stock in the offering. The Trade Desk has applied to list on the NASDAQ Global Market as TTD. The Trade Desk operates an online advertising exchange. READ MORE>>. MORE
NantCell said the price is a "significant premium" to recent equity financings. Soon-Shiong and NantCell recently was sued by investors over the "lowball" initial pricing on the deal. nantcell altor bioscience merger acquisition nantworks patrick soon shiong biotech lifescienceCulver City-based NantCell , one of the companies that is part of Dr. Patrick Soon-Shiong's NantWorks group of companies, is acquiring Altor Bioscience. The deal is worth approximately $290M. MORE
Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 xencor biopharma biopharmaceuticals merger acquisition exit MORE
San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. Setting and estimated IPO pricing range is one of the activites which leads up to a company''s IPO, and generally occurs as the company embarks on a road show to insitutional investors. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing MORE
Woodland Hills-based accounting software maker BlackLine Systems has moved one step closer to its IPO, saying this morning in a regulatory filing that it is expecting its IPO to price at betwen $13.00 blackline systems merger acquisition finance accounting software saas close financial fintech MORE
Aerie Pharmaceuticals , which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00 aerie pharmaceuticals merger acquisition exit lifescience glaucoma MORE
La Jolla-based biopharmaceuticals developer Auspex Pharmaceuticals has priced its IPO, saying it will offer up 7,000,000 shares of its common stock at $12.00 auspex pharmaceuticals merger acquisition lifescience healthcare huntington movement disorder tourette tardive dyskinesia per share. The company will begin trading this morning as ASPX on the NASDAQ Global Market. Auspex is developing treatments for Huntington''s and other orphan diseases. MORE
Earlier reports had placed the acquisition of Zenly at between $250M to $350M. snap snapchat zenly merger acquisition social networking media locationLos Angeles-based Snap Inc. paid $213.3M in cash for Zenly , the developer of a location-based social media app, in May, the company disclosed in its quarterly results on Thursday. Snap said it paid $196.1M in purchase consideration, including $186.8M in cash paid to sellers, $9.3M in liabilities due to sellers, and $17.2M MORE
San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The IPO follows one of the most active IPO and mergers and acquisitions years for Southern California last year, in 2016, and comes ahead of an anticipated IPO announcement for Venice-based Snap, Inc. anaptysbio executive biotech lifescience inflammation merger acquisition snapchat exi MORE
Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The IPO price is below its initial estimated offering price, which had been between $14.00 exit acquisition merger biopharmaceuticals biopharma xencor MORE
Santa Barbara-based Sonos , the developer of user-friendly, Internet-connected, whole-home audio systems, set its estimated IPO pricing range on Monday morning, the next step in bringing the company to market. The estimated pricing range is usually set before a company's roadshow to institutional investors, and helps to provide guidance on an ultimate pricing of the IPO, which will occur the evening before the public debut of Sonos. MORE
No pricing details on the potential deal--which the Journal said "may not result in a deal"--were released. tidal music apple computer merger acquisition rumor streaming jayzA report from the WSJ late Thursday said that Apple Computer is in discussions with music service Tidal --founded by Jay-Z--to acquire the company. READ MORE>>. MORE
The stock price of Mitek (NASDAQ:MITK) rose nearly 9 percent on the news, closing at $9.75. National blog main New York blog main San Diego San Diego blog main San Diego top stories Acquisition ASG Technologies Charles Sansbury deals Elliott fintech hostile takeover M&A Mitek Paul SingerASG Technologies, the Florida-based software company backed by activist hedge fund Elliott Management, has upped its offer for San Diego’s Mitek Systems to $11.50 per share from $10 apiece. MORE
billion price tag. veritone merger acquisition chad ryan steelberg dmarc broadcasting veri exit acaciaresNewport Beach-based Veritone , a developer of cloud-based, artificial intelligence software, says it expects its IPO to be between $14.00 and $16.00 per share, as it launches its roadshow. Veritone is looking to list as VERI on the NASDAQ Capital Market and hopes to raise as much as $20M in its IPO effort. MORE
San Diego-based Tocagen , a clinical stage gene therapy company aiming at treating cancer, has set the pricing range for its IPO. tocagen merger acquisition gene therapy cancer qualcomm jacobsThe company said in a filing that it expects to offer 7,250,000 shares of its common stock at between $10.00 and $12.00 per share. The company has applied to list as TOCA on the NASDAQ Global Market. Tocagen's IPO is being underwritten by Leerink Partners, Evercore ISI, and Stifel. MORE
San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 ignyta biotech lifescience merger acquisition cancer a share. The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. Ignyta''s offering was run by Leerink Partners and Ladenburg Thalman & Co. Ignyta is a precision medicine company targeting treatment for cancer. MORE
San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 odonate therapeutics merger acquisition chemotherapy nasdaq biotech lifescience taxane medical MORE
didn’t waste any time dropping the price of Ring Inc.’s from the prior retail price of $149.99. The announcement came on April 12 at the same time Amazon and Ring officially closed the $1 billion acquisition Amazon.com Inc. s video doorbell to $99.99 MORE
Carlsbad-based Obalon Therapeutics , which is developing a balloon-based medical device for assisting in weight loss, has set the estimated initial IPO pricing range for its public offering, saying it now expects an initial public offering at between $14.00 if it prices at the high end of its estimated range. The company has not yet set an anticipated IPO date, in what has been a busy exits and acquisition year for Southern California's technology companies. MORE
Ventura-based The Trade Desk , which operates an online advertising exchange, priced its IPO late Tuesday evening, saying that it will sell 4,666,677 shares of its Class A common stock at $18.00 The Trade Desk priced at the high end of an already increased estimated IPO range, which had been upped to between $16.00 trade desk pricing merger acquisition advertising exchange market marketplace accelerator incubator nasdaq global MORE
Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 xencor biopharma biopharmaceuticals merger acquisition exit lifescience per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. Xencor was venture backed by MedImmune Ventures, HealthCare Ventures, and others. READ MORE>>. MORE
Offering too little in an acquisition to satisfy the seller? Email readers, continue here…] There are so many ways to satisfy a seller, sometimes a seller’s ego, by making a price seem higher than the reality of the purchase. You name the price; I’ll name the terms. MORE
socalTECH
APRIL 22, 2019
Los Angeles-based Beyond Meat , which develops plant-based meat products, which look and taste like real meat, has set its IPO pricing range, as its preps to go public. According to Beyond Meat, it expects an initial offering price of between $19.00 beyond meat pricing merger acquisition bynd vegetarian veggie burger food consumer exit
Berkonomics
JANUARY 26, 2017
Offering too little in an acquisition to satisfy the seller? Email readers, continue here…] There are so many ways to satisfy a seller, sometimes a seller’s ego, by making a price seem higher than the reality of the purchase. You name the price; I’ll name the terms.
Xconomy
JANUARY 11, 2019
[ Editor’s note: Ben Fidler and Sarah de Crescenzo coauthored this report.] It is here, and then it is gone. But by the time everyone staggers to the airport or back home to sleep in their own beds, the annual few days of the J.P. Morgan Healthcare Conference and everything that mushrooms around it seem just as long as the holiday break—a distant memory!—that —that came just before. In 2020 (yes, that’s really a year), San Francisco might have a new mayor.
socalTECH
DECEMBER 7, 2017
San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 odonate therapeutics merger acquisition chemotherapy nasdaq biotech lifescience taxane medical
socalTECH
APRIL 4, 2017
San Diego-based Tocagen , a clinical stage gene therapy company aiming at treating cancer, has set the pricing range for its IPO. tocagen merger acquisition gene therapy cancer qualcomm jacobsThe company said in a filing that it expects to offer 7,250,000 shares of its common stock at between $10.00 and $12.00 per share. The company has applied to list as TOCA on the NASDAQ Global Market. Tocagen's IPO is being underwritten by Leerink Partners, Evercore ISI, and Stifel.
socalTECH
MAY 25, 2016
Culver City-based NantHealth , one of the startups out of billionaire Patrick Soon-Shiong's NantWorks portfolio, has set its IPO pricing range at between $12.50 The next step in the IPO process is the company's roadshow to investors and actual pricing of an IPO. nanthealth nantworks merger acquisition pricing personalized medicine
socalTECH
SEPTEMBER 27, 2016
Carlsbad-based Obalon Therapeutics , which is developing a balloon-based medical device for assisting in weight loss, has set the estimated initial IPO pricing range for its public offering, saying it now expects an initial public offering at between $14.00 if it prices at the high end of its estimated range. The company has not yet set an anticipated IPO date, in what has been a busy exits and acquisition year for Southern California's technology companies.
socalTECH
OCTOBER 27, 2016
Woodland Hills-based BlackLine Software , the developer of accounting and financial close software, has priced its IPO, saying late Thursday evening that it will sell 8,600,000 shares of its common stock at $17.00 BlackLine priced at the high range of an already increased estimated IPO range, which was set to $16.00 saas software accounting acquisition merger blackline
socalTECH
SEPTEMBER 21, 2016
Ventura-based The Trade Desk , which operates an online advertising exchange, priced its IPO late Tuesday evening, saying that it will sell 4,666,677 shares of its Class A common stock at $18.00 The Trade Desk priced at the high end of an already increased estimated IPO range, which had been upped to between $16.00 trade desk pricing merger acquisition advertising exchange market marketplace accelerator incubator nasdaq global
socalTECH
JUNE 11, 2014
La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 ambrx pricing merger acquisition nasdaq ambx exit biotech lifescience biopharma biopharmaceuticals protein antibody
L.A. Business Journal
APRIL 12, 2018
didn’t waste any time dropping the price of Ring Inc.’s from the prior retail price of $149.99. The announcement came on April 12 at the same time Amazon and Ring officially closed the $1 billion acquisition Amazon.com Inc. s video doorbell to $99.99
socalTECH
OCTOBER 25, 2013
Aerie Pharmaceuticals , which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00 aerie pharmaceuticals merger acquisition exit lifescience glaucoma
socalTECH
MAY 16, 2013
San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 ambit biosciences lifescience merger acquisition
socalTECH
JULY 23, 2018
Santa Barbara-based Sonos , the developer of user-friendly, Internet-connected, whole-home audio systems, set its estimated IPO pricing range on Monday morning, the next step in bringing the company to market. The estimated pricing range is usually set before a company's roadshow to institutional investors, and helps to provide guidance on an ultimate pricing of the IPO, which will occur the evening before the public debut of Sonos.
socalTECH
NOVEMBER 14, 2013
Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The IPO price is below its initial estimated offering price, which had been between $14.00 exit acquisition merger biopharmaceuticals biopharma xencor
socalTECH
FEBRUARY 22, 2012
Thousand Oaks-based Ceres , the developer of specialized seeds for the biofuels market, has priced its IPO, saying that it will offer up 5,000,000 shares of its common stock at $13.00 per share IPO range, after seeing a delay of a week in the expected pricing by the firm.
socalTECH
JULY 18, 2014
TubeMogul , which develops software to help advertisers with their online video buying, priced its IPO last night, offering up 6,250,000 shares of its common stock at $7.00 tubemogul software digital video advertising merger acquisition exit per share. The company will starts trading this morning on the NASDAQ Global Select Market as TUBE.
socalTECH
MARCH 1, 2017
has officially priced its IPO, saying on Wednesday afternoon that it will sell 200M shares of its common stock at $17.00 Snap's IPO priced above its initial estimated pricing range, which had been between $14.00 snap snapchat merger acquisition exit evan spiegel bobby murphy millionaire billionaireVenice, California-based Snap, Inc. per share. The IPO will raise $3.4 billion for Snap, the company behind Snapchat , valuing the company at approximately $24 billion.
socalTECH
SEPTEMBER 20, 2016
In a sign that reception to the company's IPO is going well, Ventura-based The Trade Desk said in a regulatory filing on Monday that it now expects its initial public offering price to be between $16.00 accelerator marketplace market exchange advertising acquisition merger pricing desk trade
socalTECH
AUGUST 4, 2014
San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. Setting and estimated IPO pricing range is one of the activites which leads up to a company''s IPO, and generally occurs as the company embarks on a road show to insitutional investors. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing
socalTECH
MARCH 14, 2014
San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 ignyta biotech lifescience merger acquisition cancer a share. The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today. Ignyta''s offering was run by Leerink Partners and Ladenburg Thalman & Co. Ignyta is a precision medicine company targeting treatment for cancer.
socalTECH
DECEMBER 3, 2013
Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 xencor biopharma biopharmaceuticals merger acquisition exit lifescience per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. Xencor was venture backed by MedImmune Ventures, HealthCare Ventures, and others. READ MORE>>.
socalTECH
FEBRUARY 5, 2014
La Jolla-based biopharmaceuticals developer Auspex Pharmaceuticals has priced its IPO, saying it will offer up 7,000,000 shares of its common stock at $12.00 auspex pharmaceuticals merger acquisition lifescience healthcare huntington movement disorder tourette tardive dyskinesia per share. The company will begin trading this morning as ASPX on the NASDAQ Global Market. Auspex is developing treatments for Huntington''s and other orphan diseases.
socalTECH
JUNE 27, 2017
NantCell said the price is a "significant premium" to recent equity financings. Soon-Shiong and NantCell recently was sued by investors over the "lowball" initial pricing on the deal. nantcell altor bioscience merger acquisition nantworks patrick soon shiong biotech lifescienceCulver City-based NantCell , one of the companies that is part of Dr. Patrick Soon-Shiong's NantWorks group of companies, is acquiring Altor Bioscience. The deal is worth approximately $290M.
socalTECH
OCTOBER 17, 2016
Woodland Hills-based accounting software maker BlackLine Systems has moved one step closer to its IPO, saying this morning in a regulatory filing that it is expecting its IPO to price at betwen $13.00 blackline systems merger acquisition finance accounting software saas close financial fintech
socalTECH
MAY 2, 2017
billion price tag. veritone merger acquisition chad ryan steelberg dmarc broadcasting veri exit acaciaresNewport Beach-based Veritone , a developer of cloud-based, artificial intelligence software, says it expects its IPO to be between $14.00 and $16.00 per share, as it launches its roadshow. Veritone is looking to list as VERI on the NASDAQ Capital Market and hopes to raise as much as $20M in its IPO effort.
Xconomy
NOVEMBER 5, 2018
The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million.
socalTECH
JANUARY 17, 2017
San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The IPO follows one of the most active IPO and mergers and acquisitions years for Southern California last year, in 2016, and comes ahead of an anticipated IPO announcement for Venice-based Snap, Inc. anaptysbio executive biotech lifescience inflammation merger acquisition snapchat exi
socalTECH
NOVEMBER 2, 2017
SendGrid , the developer of email delivery tools and back-end email services with operations in Irvine, has set its estimated IPO pricing range this morning, saying it is looking to sell 7,700,000 shares of its common stock at between $13.50 sendgrid merger acquisition send email delivery service server isaac saldana irvine
socalTECH
NOVEMBER 14, 2013
San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 tandem diabetes care diabetic medical device exit merger acquisition tndm per share. The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM.
socalTECH
FEBRUARY 8, 2012
Thousand Oaks-based Ceres , the developer of seeds for producing renewable bioenergy feedstocks, has cut its estimated IPO pricing range, ahead of its anticipated IPO this week. In an updated S-1, Ceres now estimates that it will price at between $16.00
socalTECH
AUGUST 11, 2017
Earlier reports had placed the acquisition of Zenly at between $250M to $350M. snap snapchat zenly merger acquisition social networking media locationLos Angeles-based Snap Inc. paid $213.3M in cash for Zenly , the developer of a location-based social media app, in May, the company disclosed in its quarterly results on Thursday. Snap said it paid $196.1M in purchase consideration, including $186.8M in cash paid to sellers, $9.3M in liabilities due to sellers, and $17.2M
socalTECH
NOVEMBER 4, 2013
Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 xencor biopharma biopharmaceuticals merger acquisition exit
socalTECH
JUNE 30, 2016
No pricing details on the potential deal--which the Journal said "may not result in a deal"--were released. tidal music apple computer merger acquisition rumor streaming jayzA report from the WSJ late Thursday said that Apple Computer is in discussions with music service Tidal --founded by Jay-Z--to acquire the company. READ MORE>>.
socalTECH
SEPTEMBER 7, 2016
Ventura-based The Trade Desk has set the initial estimated pricing range for its IPO, saying in a filing on Tuesday that it now expects its IPO to be between $14.00 trade desk tradedesk merger acquisition advertisingand $16.00 per share. The company is selling 4,666,667 shares of its common stock in the offering. The Trade Desk has applied to list on the NASDAQ Global Market as TTD. The Trade Desk operates an online advertising exchange. READ MORE>>.
131 
Let's personalize your content